Research and Development

The Research and Development team at Pyxis Oncology is dedicated to advancing innovative cancer therapies, focusing on the development and optimization of antibody-drug conjugates and monoclonal antibody immunotherapies. This multidisciplinary group collaborates on drug discovery, clinical operations, and regulatory compliance, ensuring the successful transition of potent biologics from the lab to clinical trials, ultimately aiming to improve outcomes for patients with challenging cancers.